These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8152612)

  • 1. The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase.
    Clow A; Freestone C; Lewis E; Dexter D; Sandler M; Glover V
    Neurosci Lett; 1993 Dec; 164(1-2):41-3. PubMed ID: 8152612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
    Thiffault C; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pergolide can induce soluble superoxide dismutase in rat striata.
    Clow A; Hussain T; Glover V; Sandler M; Walker M; Dexter D
    J Neural Transm Gen Sect; 1992; 90(1):27-31. PubMed ID: 1466876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG; McDonald IA; Bey P; Schechter PJ; Sjoerdsma A
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(6):967-87. PubMed ID: 3266532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
    Zreika M; Fozard JR; Dudley MW; Bey P; McDonald IA; Palfreyman MG
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):243-54. PubMed ID: 2597310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
    Terleckyj IA; Heikkila RE
    Ann N Y Acad Sci; 1992 May; 648():365-7. PubMed ID: 1637071
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates.
    Boismenu D; Mamer O; Ste-Marie L; Vachon L; Montgomery J
    J Mass Spectrom; 1996 Oct; 31(10):1101-8. PubMed ID: 8916419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species.
    Yu PH; Zuo DM
    Biochem Pharmacol; 1992 Jan; 43(2):307-12. PubMed ID: 1739419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain.
    Thiffault C; Quirion R; Poirier J
    Synapse; 1998 Mar; 28(3):208-11. PubMed ID: 9488505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
    Dudley MW
    Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
    Glover V; Clow A; Sandler M
    J Neural Transm Suppl; 1993; 40():37-45. PubMed ID: 8294899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates.
    Thomas CE; Huber EW; Ohlweiler DF
    Free Radic Biol Med; 1997; 22(4):733-7. PubMed ID: 9013137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprenyl and pergolide rescue spinal motor neurons from axotomy-induced neuronal death in the neonatal rat.
    Iwasaki Y; Ikeda K; Shiojima T; Kobayashi T; Tagaya N; Kinoshita M
    Neurol Res; 1996 Apr; 18(2):168-70. PubMed ID: 9162873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased acetylcholinesterase activity in selected regions of rat brain after chronic (-)-deprenyl administration.
    Lakshmana MK; Jagadeesh S; Subhash MN
    Neurochem Res; 1996 Oct; 21(10):1209-12. PubMed ID: 8923482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDL 72,974A: a selective MAO-B inhibitor with potential for treatment of Parkinson's disease.
    Palfreyman MG; McDonald IA; Zreika M; Cremer G; Haegele KD; Bey P
    J Neural Transm Suppl; 1993; 40():101-11. PubMed ID: 8294896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
    Finnegan KT; Skratt JJ; Irwin I; DeLanney LE; Langston JW
    Eur J Pharmacol; 1990 Aug; 184(1):119-26. PubMed ID: 2120076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of the tolerability and effects on platelet MAO-B activity of single oral doses of MDL 72.974A in normal volunteers.
    Hinze C; Harland D; Zreika M; Dulery B; Hardenberg J
    J Neural Transm Suppl; 1990; 32():203-9. PubMed ID: 2089092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of (-)-deprenyl increases mortality in male Wistar rats.
    Gallagher IM; Clow A; Glover V
    J Neural Transm Suppl; 1998; 52():315-20. PubMed ID: 9564632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDL 72145, an enzyme-activated irreversible inhibitor with selectivity for monoamine oxidase type B.
    Zreika M; McDonald IA; Bey P; Palfreyman MG
    J Neurochem; 1984 Aug; 43(2):448-54. PubMed ID: 6736960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.